SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration.
Área: Diabetes
Año: 2023 URL: https://doi.org/10.1093/eurheartj/ehad260 Referencia: SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J. 2023;44(28):2544-2556. doi:10.1093/eurheartj/ehad260
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Guías ESC 2023 para el manejo de la enfermedad cardiovascular en pacientes con diabetes.
Área: Diabetes
Año: 2023 URL: 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes Referencia: Marx N, Federici M, Schütt K, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes [published correction appears in Eur Heart J. 2023 Nov 22;:]. Eur Heart J. 2023;44(39):4043-4140. doi:10.1093/eurheartj/ehad192
Área: Diabetes
Año: 2022 URL: https://www.revclinesp.es/es-resumen-ejecutivo-sobre-el-tratamiento-articulo-S0014256522000686 Referencia: Gómez-Peralta F, Carrasco-Sánchez FJ, Pérez A, et al. Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document «Treatment of type 2 diabetes mellitus in the elderly». Rev Clin Esp (Barc). 2022;222(8):496-499.